Ileal Crohn's disease: CEUS determination of activity

Abdominal Imaging

Volumn 37, Issue 3, 2012, Pages 359-368

  De Franco, Antonio ^a   Marzo, Manuela ^a   Felice, Carla ^a   Pugliese, Daniela ^a   Di Veronica, Alessandra ^a   Bonomo, Lorenzo ^a   Armuzzi, Alessandro ^a   Guidi, Luisa ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

CEUS; Crohn's disease; SonoVue; Ultrasound

Indexed keywords

BIOLOGICAL PRODUCT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; SHU 508; SONOVUE;

ARTICLE; COMPUTER PROGRAM; CONTRAST ENHANCED ULTRASONOGRAPHY; CONTRAST ENHANCEMENT; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ECHOGRAPHY; FOLLOW UP; HUMAN; ILEUM DISEASE; NON INVASIVE PROCEDURE; PATIENT MONITORING; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TRANSDUCER; TREATMENT RESPONSE;

CONTRAST MEDIA; CROHN DISEASE; HUMANS; ILEAL DISEASES; IMAGE INTERPRETATION, COMPUTER-ASSISTED; PHOSPHOLIPIDS; POLYSACCHARIDES; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE;

EID: 84863718578     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-011-9831-9     Document Type: Article

References (46)

1. Stange EF, Travis SPL, Vermeire S, et al. (2006) European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 55(Supplement 1):i1-i15. doi:10.1136/gut.2005.081950a
2. Satsangi J, Silverberg MS, Vermeire S, et al. (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55(6):749-753
3. Schnitzler F, Fidder H, Ferrante M, et al. (2009) Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 15(9):1295-1301
4. Baert F, Moortgat L, Van Assche G, et al. (2010) Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 138:463-468
5. Huprik JE, Fletcher JG (2009) CT enterography: principles, technique and utility in Crohn's disease. Eur J Radiol 69(3):393-397
6. Siddiki H, Fidler J (2009) MR imaging of the small bowel in Crohn's disease. Eur J Radiol 69(3):409-417
7. Van Assche G, Dignass A, Panes J, et al. (2010) The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 4:7-27
8. Quaia E (2007) Microbubble ultrasound contrast agents: an update. Eur Radiol 17(8):1995-2008
9. Wilson SR, Burns PN (2010) Microbubble-enhanced US in body imaging: what role? Radiology 257(1):24-39
10. Piscaglia F, Bolondi L (2006) Italian Society for Ultrasound in Medicine, Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32(9):1369-1375
11. Torzilli G (2005) Adverse effects associated with SonoVue use. Expert Opin Drug Saf 4(3):399-401
12. Geleijnse ML, Nemes A, Vletter WB, et al. (2009) Adverse reactions after the use of sulphur hexafluoride (SonoVue) echo contrast agent. J Cardiovasc Med 10(1):75-77
13. Maconi G, Parente F, Bollani S, et al. (1996) Abdominal ultrasound in the assessment of extent and activity of Crohn's disease: clinical significance and implication of bowel wall thickening. Am J Gastroenterol 91(8):1604-1609
14. Fraquelli M, Colli A, Casazza G, et al. (2005) Role of US in detection of Crohn disease: meta-analysis. Radiology 236(1):95-101
15. Migaleddu V, Scanu AM, Quaia E, et al. (2009) Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease. Gastroenterology 137(1):43-52
16. Castiglione F, de Sio I, Cozzolino A, et al. (2004) Bowel wall thickness at abdominal ultrasound and the one-year-risk of surgery in patients with Crohn's disease. Am J Gastroenterol 99(10):1977-1983
17. Rigazio C, Ercole E, Laudi C, et al. (2009) Abdominal bowel ultrasound can predict the risk of surgery in Crohn's disease: proposal of an ultrasonographic score. Scand J Gastroenterol 44(5): 585-593
18. Rispo A, Bucci L, Pesce G, et al. (2006) Bowel sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis 12(6):486-490
19. Zalis M, Singh AK (2004) Imaging of inflammatory bowel disease: CT and MR. Scand J Gastroenterol 43(6):719-726
20. Nylund K, Leh S, Immervoll H, et al. (2008) Crohn's disease: comparison of in vitro ultrasonographic images and histology. Scand J Gastroenterol 43:719-726
21. Maconi G, Carsana L, Fociani P, et al. (2003) Small bowel stenosis in Crohn's disease: clinical, biochemical and ultrasonographic evaluation of histological features. Aliment Pharmacol Ther 18(7): 749-756
22. Migaleddu V, Quaia E, Scano D, et al. (2008) Inflammatory activity in Crohn disease: ultrasound findings. Abdom Imaging 33(5):589-597
23. Maconi G, Sampietro GM, Parente F, et al. (2003) Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study. Am J Gastroenterol 98(7):1545-1555
24. Gasche C, Moser G, Turetschek K, et al. (1999) Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut 44(1):112-117
25. Spalinger J, Patriquin H, Miron MC, et al. (2000) Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 217(3):787-791
26. Esteban JM, Maldonado L, Sanchiz V, et al. (2001) Activity of Crohn's disease assessed by colour Doppler ultrasound analysis of the affected loops. Eur Radiol 11:1423-1428
27. Drews BH, Barth TF, Hänle MM, et al. (2009) Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn's disease. Eur Radiol 19(6):1379-1386
28. Yekeler E, Danalioglu A, Movasseghi B, et al. (2005) Crohn disease activity evaluated by Doppler ultrasonography of the superior mesenteric artery and the affected small-bowel segments. J Ultrasound Med 24(1):59-65
29. Ludwig D, Wiener S, Brüning A, et al. (1999) Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: a prospective follow-up study. Am J Gastroenterol 94(10): 2942-2950
30. Byrne MF, Farrell MA, Abass S, et al. (2001) Assessment of Crohn's disease activity by Doppler sonography of the superior mesenteric artery, clinical evaluation and the Crohn's disease activity index: a prospective study. Clin Radiol 56(12):973-978
31. Di Sabatino A, Fulle I, Ciccocioppo R, et al. (2002) Doppler enhancement after intravenous levovist injection in Crohn's disease. Inflamm Bowel Dis 8(4):251-257
32. Rapaccini GL, Pompili M, Orefice R, et al. (2004) Contrastenhanced power Doppler of the intestinal wall in the evaluation of patients with Crohn disease. Scand J Gastroenterol 39(2):188-194
33. Robotti D, Cammarota T, Debani P, et al. (2004) Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography. Abdom Imaging 29(6):648-652
34. Serra C, Menozzi G, Labate AM, et al. (2007) Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 62(1):114-121
35. Parente F, Maconi G, Bollani S, et al. (2002) Bowel ultrasound in assessment of Crohn's disease and detection of related small bowel strictures: a prospective comparative study versus x ray and intraoperative findings. Gut 50(4):490-495
36. Limberg B (1999) Diagnosis of chronic inflammatory bowel disease by ultrasonography. Z Gastroenterol 37(6):495-508
37. Kratzer W, Schmidt SA, Mittrach C, et al. (2005) Contrast-enhanced wideband harmonic imaging ultrasound (SonoVue): a new technique for quantifying bowel wall vascularity in Crohn's disease. Scand J Gastroenterol 40(8):985-991
38. Guidi L, De Franco A, De Vitis I, et al. (2006) Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease. Eur Rev Med Pharmacol Sci 10(1):23-26
39. De Franco A, Di Veronica A, Bock E, et al. (2011) Ileal Crohn's Disease: mural microvascularity quantified by contrast-enhanced ultrasound correlates with disease activity. Radiology (Accepted)
40. Schreyer AG, Finkenzeller T, Gössmann H, et al. (2008) Microcirculation and perfusion with contrast enhanced ultrasound (CEUS) in Crohn's disease: first results with linear contrast harmonic imaging (CHI). Clin Hemorheol Microcirc 40(2):143-155
41. Girlich C, Jung EM, Iesalnieks I, et al. (2009) Quantitative assessment of bowel wall vascularisation in Crohn's disease with contrast-enhanced ultrasound and perfusion analysis. Clin Hemorheol Microcirc 43(1):141-148
42. Girlich C, Jung EM, Huber E, et al. (2011) Comparison between preoperative quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and operative macroscopic findings and results of histopathological scoring in Crohn's disease. Ultraschall Med 32(2):154-159
43. Quaia E, Migaleddu V, Baratella E, et al. (2009) The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn's disease Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. Eur J Radiol 69(3):438-444
44. Schirin-Sokhan R, Winograd R, Tischendorf S, et al. (2011) Assessment of inflammatory and fibrotic stenoses in patients with Crohn's disease using contrast-enhanced ultrasound and computerized algorithm: a pilot study. Digestion 83(4):263-268
45. Ripollés T, Martínez MJ, Paredes JM, et al. (2009) Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 253(1):241-248
46. Kumar P, Domjan J, Bhandari P, et al. (2009) Is there an association between intestinal perfusion and Crohn's disease activity? A feasibility study using contrast-enhanced ultrasound. Br J Radiol 82(974):112-117